Moleculin Biotech, Inc.
MBRX
$2.38
-$0.03-1.25%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 2.49M | 2.41M | 2.15M | 2.09M | 2.48M |
| Depreciation & Amortization | 8.00K | 9.00K | 21.00K | 29.00K | 31.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.87M | 7.53M | 5.91M | 5.72M | 5.94M |
| Operating Income | -7.87M | -7.53M | -5.91M | -5.72M | -5.94M |
| Income Before Tax | -12.85M | 15.55M | -25.40M | -17.28M | -5.90M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -12.85M | 15.55M | -25.40M | -17.28M | -5.90M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -12.85M | 15.55M | -25.40M | -17.28M | -5.90M |
| EBIT | -7.87M | -7.53M | -5.91M | -5.72M | -5.94M |
| EBITDA | -7.87M | -7.52M | -5.88M | -5.69M | -5.91M |
| EPS Basic | -3.54 | 6.90 | -17.02 | -27.28 | -15.80 |
| Normalized Basic EPS | -1.95 | 4.34 | -10.64 | -17.05 | -9.87 |
| EPS Diluted | -3.54 | 6.90 | -17.02 | -27.28 | -15.80 |
| Normalized Diluted EPS | -1.95 | 4.34 | -10.64 | -17.05 | -9.87 |
| Average Basic Shares Outstanding | 4.12M | 2.24M | 1.49M | 633.30K | 373.80K |
| Average Diluted Shares Outstanding | 4.12M | 2.24M | 1.49M | 633.30K | 373.80K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |